Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $37.4615.

A number of research analysts recently weighed in on OPCH shares. Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. Jefferies Financial Group reiterated a “buy” rating and issued a $37.00 price target on shares of Option Care Health in a research report on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft boosted their price objective on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, December 9th. Bank of America raised their target price on Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. Finally, Stephens raised Option Care Health to a “strong-buy” rating in a report on Thursday, December 11th.

Option Care Health Price Performance

OPCH opened at $35.33 on Wednesday. The firm has a 50-day moving average price of $32.56 and a 200-day moving average price of $29.78. Option Care Health has a twelve month low of $24.24 and a twelve month high of $36.80. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $5.61 billion, a price-to-earnings ratio of 28.04, a PEG ratio of 2.16 and a beta of 0.80.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in OPCH. Royal Bank of Canada increased its holdings in shares of Option Care Health by 20.7% in the first quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock worth $8,078,000 after purchasing an additional 39,661 shares during the period. AQR Capital Management LLC increased its stake in Option Care Health by 162.6% in the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after acquiring an additional 25,777 shares during the last quarter. Empowered Funds LLC bought a new position in Option Care Health in the 1st quarter worth about $208,000. USA Financial Formulas purchased a new stake in shares of Option Care Health in the 2nd quarter valued at about $26,000. Finally, Blair William & Co. IL boosted its position in shares of Option Care Health by 67.9% during the 2nd quarter. Blair William & Co. IL now owns 78,693 shares of the company’s stock valued at $2,556,000 after acquiring an additional 31,821 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.